TY - JOUR
T1 - In vitro Pharmacodynamics of Enrofloxacin Against an Escherichia coli gyrA Mutant
AU - Sorucu, Ali AU - Arslan, Erdem AU - Cengiz, Murat
JO - Journal of Animal and Veterinary Advances
VL - 10
IS - 18
SP - 2384
EP - 2388
PY - 2011
DA - 2001/08/19
SN - 1680-5593
DO - javaa.2011.2384.2388
UR - https://makhillpublications.co/view-article.php?doi=javaa.2011.2384.2388
KW - Turkey
KW -Pharmacodynamic of enrofloxacin
KW -Escherichia coli
KW -C-T mutation
KW -microdilution
KW -significant
AB - The aim of this study was to investigate in vitro the pharmacodynamics of Enrofloxacin (ENR) against an Escherichia coli gyrA mutant (E. coli MT/128). Broth microdilution testing was used to determine the Minimum Inhibitory Concentration (MIC) amd multi-step resistance selection was performed until reaching 1 μg mL•1 MIC. For time-kill experiments, colony counts were determined by plating each diluted sample onto Plate Count Agar and an integrated pharmacokinetic/pharmacodynamics area measure (log ratio area) was applied to all cfu data. A single C-T mutation was found in gyrA at codon 83. Concentration-dependent bacterial killing was observed for E. coli MT/128. Bactericidal activity for this strain was achieved within 4 h at concentrations • 8 times the MIC with no significant regrowth by 24 h.
ER -